Evidence map›Paper›PMID 37755097›Full record

ReviewMarine drugs2023

Ana Débora Nunes Pinheiro Georgii, Valéria Laneuville Teixeira

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ana Débora Nunes Pinheiro GeorgiiAlgamar Laboratory, Institute of Biology, Fluminense Federal University, Rua Prof. Frames Waldemar de Freitas Reis, Block M, São Domingos, Niterói 24210-201, RJ, Brazil.ORCID 0000-0002-3562-4310
Valéria Laneuville TeixeiraAlgamar Laboratory, Institute of Biology, Fluminense Federal University, Rua Prof. Frames Waldemar de Freitas Reis, Block M, São Domingos, Niterói 24210-201, RJ, Brazil.ORCID 0000-0003-4962-6912
Universidade Federal Fluminense · BR

Funding

Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho E-26/201.006/2022
6 · The paper itself

Abstract

Dictyotaceae algae have gained recognition as prolific producers of diterpenes, which are molecules with significant biotechnological potential. These diterpenes hold immense promise as potential active drug components, making the algae a compelling area of study. The present review aims to present the latest advancements in understanding the biopotential of Brazilian Dictyota and Canistrocarpus brown algae, shedding light on the remarkable diversity and the biological and pharmacological potential of the secondary metabolites they produce. A total of 78 articles featuring 26 distinct diterpenes are reported in this review, with their antiviral potential being the mosthighlighted biological activity. Despite considerable research on these algae and their diterpenes, significant knowledge gaps persist. Consequently, the present review is poised to serve as a pivotal resource for researchers who are actively engaged in the pursuit of active diterpenes beyond the immediate purview. Furthermore, it holds the potential to catalyze an increase in research endeavors centered around these algal species within the geographical confines of the Brazilian coastline. Also, it assumes a critical role in directing future scientific explorations toward a better comprehension of these compounds and their ecological implications.

Indexed as

DiterpenesPhaeophyceaeAntiviral AgentsBiotechnologyBrazilAntiviral AgentsDiterpenesbiological propertiesDictyotaceaediterpenesmacroalgaemarine natural products

Identifiers

PMID37755097
PMCPMC10532921
OpenAlexW4386416371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.